2 days Fortress Biotech (FBIO) Reports Q4 Loss, Lags Revenue Estimates Zacks
Fortress Biotech (FBIO) delivered earnings and revenue surprises of 67.09% and 12.58%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
X